DIVISLAB's weekly performance was disappointing, with a return of -1.86% and a Sharpe Ratio of -1.26, indicating poor risk-adjusted returns. The stock's volatility was moderate at 5.88%, but its Max Drawdown of -1.86% suggests a significant decline in value. Compared to its peers, DIVISLAB underperformed DRREDDY and SUNPHARMA, but outperformed CIPLA. Overall, the stock was relatively risky this week.

[Volatility: 5.88%]